- Home
- FOR vs ARDX Comparison
FOR vs ARDX Comparison
Compare FOR & ARDX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FOR
- ARDX
- Stock Information
- Founded
- FOR 2005
- ARDX 2007
- Country
- FOR United States
- ARDX United States
- Employees
- FOR N/A
- ARDX N/A
- Industry
- FOR Real Estate
- ARDX Biotechnology: Pharmaceutical Preparations
- Sector
- FOR Finance
- ARDX Health Care
- Exchange
- FOR Nasdaq
- ARDX Nasdaq
- Market Cap
- FOR 1.4B
- ARDX 1.2B
- IPO Year
- FOR 2007
- ARDX 2014
- Fundamental
- Price
- FOR $25.99
- ARDX $4.82
- Analyst Decision
- FOR Strong Buy
- ARDX Buy
- Analyst Count
- FOR 3
- ARDX 7
- Target Price
- FOR $38.67
- ARDX $11.75
- AVG Volume (30 Days)
- FOR 141.9K
- ARDX 4.0M
- Earning Date
- FOR 01-21-2025
- ARDX 10-31-2024
- Dividend Yield
- FOR N/A
- ARDX N/A
- EPS Growth
- FOR 20.12
- ARDX N/A
- EPS
- FOR 4.00
- ARDX N/A
- Revenue
- FOR $1,509,400,000.00
- ARDX $251,849,000.00
- Revenue This Year
- FOR $9.25
- ARDX $168.07
- Revenue Next Year
- FOR $11.64
- ARDX $22.65
- P/E Ratio
- FOR $6.49
- ARDX N/A
- Revenue Growth
- FOR 5.05
- ARDX 87.57
- 52 Week Low
- FOR $25.36
- ARDX $4.32
- 52 Week High
- FOR $40.92
- ARDX $10.13
- Technical
- Relative Strength Index (RSI)
- FOR 27.28
- ARDX 40.87
- Support Level
- FOR $28.13
- ARDX $4.32
- Resistance Level
- FOR $27.77
- ARDX $5.47
- Average True Range (ATR)
- FOR 0.88
- ARDX 0.35
- MACD
- FOR -0.25
- ARDX -0.06
- Stochastic Oscillator
- FOR 12.80
- ARDX 32.26
About FOR Forestar Group Inc
Forestar Group Inc is a residential lot development company with operations across the United States. The core business segment for the company is real estate which generates all of it's revenues. The firm fundamentally acquires entitled real estate and develops it into finished residential lots for sale to homebuilders with a strategic focus on asset turns and efficiency. Single-family residential communities account for the majority of their real estate projects. The company utilizes a lower-risk business model mainly by investing in short duration, phased development projects.
About ARDX Ardelyx Inc.
Ardelyx Inc is a biotechnology company focused on the discovery, development, and commercialization of innovative, first-in-class medicines that meet significant unmet medical needs. The company has a proprietary drug discovery and design platform. Its lead product candidate is tenapanor, which aims to reduce the absorption of dietary sodium and phosphorus for the treatment of kidney disease, irritable bowel syndrome with constipation, and hyperphosphatemia in patients with dialysis.